Drug-induced agranulocytosis: Clinical study of 19 cases;Agranulocitosis inducida por farmacos: Estudio clinico de 19 casos

Sangre

Volumn 43, Issue 5, 1998, Pages 436-438

  Márquez, José Antonio ^a   Pardo, Cristina ^a   Amutio, Elena ^a   Cortés, Cristina ^a   Piñán, M Angeles ^a   Alvarez, Carmen ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DICLOFENAC; DIPYRONE; GRANULOCYTE COLONY STIMULATING FACTOR; PHENYTOIN; TETRAZEPAM; TICLOPIDINE;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FEMALE; FEVER; HUMAN; INFECTION; MALE; NEUTROPENIA; CHEMICALLY INDUCED DISORDER; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; AGRANULOCYTOSIS; DIPYRONE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; TICLOPIDINE;

EID: 0032176390     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Petz LD, Fudenburg HH. Immunologic mechanisms in drug induced cytopenias. Prog Hematol 1975; 9: 185-206.
2. Corzo D, Yunis JJ, Salazar M, Lieberman JA, Howard A, Awdeh Z et al. The major histocompatibility complex region marked by HSP701 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups. Blood 1995; 86: 3835-3840.
3. Vlahov V, Bacracheva N, Tontcheva D, Naumova E, Mavrudieva M, Ilieba P et al. Genetic factors and risk of agranulocytosis from metamizol. Pharmacogenetics 1996; 6: 67-72.
4. The International Agranulocytosis and Aplastic Anemia Study. Risk of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 1986; 256: 1749-1759.
5. Paitel JF, Stockemer V, Dorvaux V, Witz F, Guerci A, Lederlin P. Acute drug-induced agranulocytosis. Clinical study of 30 patients and evolution of etiologies over 2 decades. Rev Med Interne 1995; 16: 495-499.
6. Kauffman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis an aplastic anemia. Nueva York: Oxford University Press, 1991: 170-203.
7. Owens DG. Adverse effects of antipsychotic agents. Do newer agents offer advantages? Drugs 1996; 51: 895-930.
8. Ito MK, Smith AR, Lee ML. Ticlopidine: a new platelet aggregation inhibitor. Clin Pharm 1992; 11: 603-617.
9. Framptom JE, Lee CR, Faulds D. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 1994; 48: 731-760.
10. Mani S, Barry M, Concato J. Granulocyte-colony stimulating factor therapy in drug-induced agranulocytosis. Arch intern Med 1993, 153: 2500-2501.
11. Seprikkelman A, De Wolf JT, Vellenga E. The application of hematopoietic growth factor in drug-induced agranulocytosis: a review of 70 cases Leukemia 1994; 8: 2031-2036.